Vivek Ramana 4
4 · PetLife Pharmaceuticals, Inc. · Filed Mar 2, 2018
Insider Transaction Report
Form 4
Vivek Ramana
Chief Medical Officer
Transactions
- Other
Common Stock
2017-08-17−1,000,000→ 1,000,000 total - Other
Series A Preferred Stock
2017-08-17+1,000,000→ 1,000,000 total - Award
Common Stock
2016-10-27$0.67/sh+1,000,000$670,000→ 2,000,000 total
Footnotes (2)
- [F1]Issued shares as compensation pursuant to employment contract.
- [F2]Conversion of common stock into Series A Preferred Stock on a 1:1 basis.